Any deal would be similar to what you see in overs

Any deal would be similar to what you see in overseas deals where the overseas company takes care of distribution of current and future indications for that drug. Quite a few of those deals are signed pre-approval and are contingent upon approval. The one question is if any big pharma is going to offer an appropriate deal. Ten to one they're all low-balling it.